About
EnsoData, based in Madison, Wisconsin, is a pioneering healthcare AI company dedicated to transforming clinical waveform data into actionable insights. They develop FDA-cleared Software as a Medical Device (SaMD) solutions that significantly enhance the accuracy, efficiency, and affordability of healthcare, with a primary focus on sleep medicine. Their innovative platforms, EnsoSleep and EnsoHST, leverage advanced artificial intelligence to automate sleep study scoring and facilitate comprehensive multi-night home sleep testing, respectively.
EnsoSleep provides substantial time savings for clinicians by automating the analysis of polysomnograms (PSGs) and home sleep apnea tests (HSATs), while EnsoHST offers comfortable, multi-signal home testing devices to streamline the diagnosis of sleep disorders. Complementary tools like Celeste+ and Therapy Track further optimize data collection and enable long-term therapy monitoring for various treatments. EnsoData's mission is to address the significant population of undiagnosed sleep apnea patients and alleviate the workload on healthcare professionals.
Beyond sleep, EnsoData envisions a future where its waveform AI can unlock dormant clinical data to detect and manage a broad spectrum of conditions, including heart disease, diabetes, seizure disorders, and neurodegenerative diseases. By empowering clinicians with intelligent tools, EnsoData aims to improve patient outcomes, expand access to essential health services, and make healthcare more accessible globally.